At present, there are many kinds of drugs for heart failure. the new drug LCZ696 (sacubitril/valsartan) is the first approved agent of a novel class of agents combining a neprilysin inhibitor and an ARB. There are currently no alternatives in this class is recommended by US guidelines as a first-line treatment for chronic heart failure. ...